Search | Page 18 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. What is Secondary MDS? Everything You Need to Know

    ... who have been previously treated for cancer with chemotherapy or radiation therapy. During this recorded program on May ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  2. MDS Progression to AML: What Patients Need to Know

    ... myeloid leukemia (AML), which does not respond well to chemotherapy . AML is a bone marrow malignancy where the marrow is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  3. MDS Progression to AML: What Patients Need to Know

    ... myeloid leukemia (AML), which does not respond well to chemotherapy . AML is a bone marrow malignancy where the marrow is ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  4. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... myeloproliferative disorders (MPD). Giving low doses of chemotherapy , such as fludarabine phosphate, and total-body irradiation ... transplant helps stop the growth of cancer cells. Giving chemotherapy or radiation therapy before or after transplant also stops the ...

    Clinical Trial last updated 04/27/2016 - 1:27pm.

  5. Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

    ... therapies At least 3 weeks beyond the last chemotherapy , targeted anticancer agent, major surgery or experimental ...

    Clinical Trial last updated 06/06/2016 - 10:47am.

  6. Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma

    ... is effective as a single agent and in combination with chemotherapy for indolent Non-Hodgkin's Lymphoma. The purpose of this ...

    Clinical Trial last updated 06/06/2016 - 10:17am.

  7. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... if bone marrow transplantation (BMT) followed by chemotherapy will help people with aplastic anemia who have failed ... one or more immunosuppressive treatments. High dose chemotherapy followed by bone marrow transplantation (BMT) has been used to ...

    Clinical Trial last updated 04/21/2016 - 1:19pm.

  8. Clinical Trials Report for October 2015

    ... identifier: NCT02281084 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced ... clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or ...

    Page last updated 09/30/2015 - 10:53am.

  9. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... also approved by the FDA. Melphalan is an FDA-approved chemotherapy for multiple myeloma and is used as a high-dose conditioning ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  10. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... be used for AML. Prior therapy with hydroxyurea, chemotherapy , biological or targeted therapy (e.g. FLT3 inhibitors, other ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.